Drug Type Small molecule drug |
Synonyms Compound 32d(Actelion), ACT 387042 |
Action inhibitors |
Mechanism Bacterial DNA gyrase inhibitors(Bacterial DNA gyrase inhibitors), Bacterial top IV inhibitors(Bacterial topoisomerase IV inhibitors) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H26FN5O4S |
InChIKeyJYSPYEGADQXZPH-VMDGZTHMSA-N |
CAS Registry1229514-11-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pneumococcal Infections | Preclinical | Switzerland | 23 Dec 2014 | |
Staphylococcus Aureus Infections | Preclinical | Switzerland | 23 Dec 2014 | |
Pneumonia, Staphylococcal | Discovery | Switzerland | 23 May 2016 |